Desloratadine

Desloratadine
Desloratadine
Systematic (IUPAC) name
8-chloro-6,11-dihydro-11-(4-piperdinylidene)- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine
Clinical data
Trade names Clarinex
AHFS/Drugs.com monograph
MedlinePlus a602002
Licence data EMA:LinkUS FDA:link
Pregnancy cat. B1(AU) C(US)
Legal status POM (UK) -only (US)
Routes oral
Pharmacokinetic data
Bioavailability Rapidly absorbed
Protein binding 85%
Metabolism Liver
Half-life 27 hours
Excretion 40% as conjugated metabolites into urine
Similar amount into the feces
Identifiers
CAS number 100643-71-8 YesY
ATC code R06AX27
PubChem CID 124087
DrugBank APRD00324
ChemSpider 110575 YesY
UNII FVF865388R YesY
KEGG D03693 YesY
ChEBI CHEBI:291342 YesY
ChEMBL CHEMBL1172 YesY
Chemical data
Formula C19H19ClN2 
Mol. mass 310.82
SMILES eMolecules & PubChem
 N(what is this?)  (verify)

Desloratadine is a drug used to treat allergies. It is marketed under several trade names such as NeoClarityn, Claramax, Clarinex, Larinex, Aerius, Dazit, Azomyr and Delot. It is an active metabolite of loratadine, which is also on the market.

Contents

Available forms

Desloratadine is available as tablets (including orally disintegrating and extended release) and as syrup.[1]

Mechanism of action

Desloratadine is a tricyclic antihistamine, which has a selective and peripheral H1-antagonist action. It is an antagonist at histamine H1 receptors, and an antagonist at all subtypes of the muscarinic acetylcholine receptor. It has a long-lasting effect and in moderate and low doses, does not cause drowsiness because it does not readily enter the central nervous system.[2]

Side effects

Most common side-effects are fatigue, dry mouth, headache, and gastrointestinal disturbances.

Desloratadine vs. loratadine

Desloratadine is the major metabolite of loratadine. There are no head-to-head randomised controlled trials of the two drugs. A survey of patients dissatisfied with loratadine published in August 2003 reported equal or better satisfaction with desloratadine,[3] concluding:

When severity of disease was controlled for in the analysis, a pattern emerged suggesting greater levels of satisfaction amongst loratadine dissatisfied patients who converted to desloratadine. Point estimates suggest a consistent pattern favoring desloratadine patient satisfaction, with statistically significant results reported for sum of adverse effects, nighttime awakening due to symptoms, symptom severity just prior to the next dose, and overall satisfaction (p < 0.05).

A November 2003 article published in the journal American Family Physician about the safety, tolerability, effectiveness, price, and simplicity of desloratadine concluded the following:[4]

Desloratadine is similar in effectiveness to fexofenadine and would be expected to produce results similar to loratadine and other nonsedating antihistamines. There is no clinical advantage to switching a patient from loratadine to desloratadine. However, it may be an option for patients whose medical insurance no longer covers loratadine if the co-pay is less than the cost of the over-the-counter product.

In Canada, desloratadine is available without a prescription, and as a generic. Prices are comparable to those of loratadine.

References

  1. ^ FDA Electronic Orange Book http://www.fda.gov/cder/ob/default.htm.
  2. ^ Mann R, Pearce G, Dunn N, Shakir S (2000). "Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice". BMJ 320 (7243): 1184–6. doi:10.1136/bmj.320.7243.1184. PMC 27362. PMID 10784544. http://bmj.bmjjournals.com/cgi/content/full/320/7243/1184. 
  3. ^ Glass D, Harper A (August 13, 2003). "Assessing satisfaction with desloratadine and fexofenadine in allergy patients who report dissatisfaction with loratadine". BMC Fam Pract 4: 10. doi:10.1186/1471-2296-4-10. PMC 194638. PMID 12917016. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=194638. 
  4. ^ See S (2003). "Desloratadine for allergic rhinitis". Am Fam Physician 68 (10): 2015–6. PMID 14655812. http://www.aafp.org/afp/20031115/steps.html. 

Wikimedia Foundation. 2010.

Игры ⚽ Нужно решить контрольную?

Look at other dictionaries:

  • Desloratadine — Général Nom IUPAC 8 chloro 6,11 dihydro 11 (4 pipérdinylidène) 5H benzo[5,6]cyclohepta[1,2 b]pyridine N …   Wikipédia en Français

  • desloratadine — noun An active metabolite of loratadine, used to treat allergies …   Wiktionary

  • desloratadine — des·lo·rat·a·dine .dez lə rat ə .dēn, .dīn n a long acting H1 antagonist C19H19ClN2 that is used to treat seasonal and perennial allergic rhinitis and chronic hives see clarinex * * * des·lor·at·a·dine (des″lə ratґə dēn) a… …   Medical dictionary

  • 100643-71-8 — Desloratadine Desloratadine Général No CAS …   Wikipédia en Français

  • Aerius — Desloratadine Desloratadine Général No CAS …   Wikipédia en Français

  • C19H19ClN2 — Desloratadine Desloratadine Général No CAS …   Wikipédia en Français

  • Loratadine — Systematic (IUPAC) name …   Wikipedia

  • H1 antagonist — An H1 antagonist is a histamine antagonist of the H1 receptor that serves to reduce or eliminate effects mediated by histamine, an endogenous chemical mediator released during allergic reactions. Agents where the main therapeutic effect is… …   Wikipedia

  • Azelastine — Systematic (IUPAC) name (RS) 4 [(4 chlorophenyl)methyl] 2 (1 methylazepan 4 yl) phthalazin 1 one Clinical data Trade names …   Wikipedia

  • Histamine antagonist — A histamine antagonist, commonly referred to as antihistamine, is a pharmaceutical drug that inhibits action of histamine by blocking it from attaching to histamine receptors. Contents 1 Clinical effects 2 Clinical: H1 and H2 receptor antagonists …   Wikipedia

Share the article and excerpts

Direct link
Do a right-click on the link above
and select “Copy Link”